Gedea Biotech
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$5.03M
Company Overview
Gedea Biotech operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a VC Round in November 2023.
Gedea Biotech is a biotechnology company that develops pHyph, an antibiotic-free treatment for vaginal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gedea Biotech Comparables
Compare Gedea Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yaso Therapeutics, Inc. | 79% | |
| Osel Inc. | 77% | |
| Coologics | 77% |
For institutional investors. Book with your work email.
Gedea Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| VC Round | Nov 15, 2023 | ||||
| VC Round | May 24, 2023 | ||||
| Grant | Apr 4, 2023 | ||||
| VC Round | Oct 28, 2021 | ||||
Grant | Dec 11, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gedea Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Almi Invest AB | Seed |
| Vinnova | Grant |
| Porte-Monnaie Venture | Seed |
| Swelife | Grant |
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 182% MoM, reaching 1.3K.
- Jan 27, 2026
Julie Waras Brogren appointed as new CEO.
For institutional investors. Book with your work email.
Gedea Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gedea Biotech's valuation, stock price, and market status.
Is Gedea Biotech a public or private company?
Gedea Biotech is a private company.
What is the current stock price of Gedea Biotech?
Gedea Biotech is a private company, so its shares have no public market price. Caplight tracks Gedea Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gedea Biotech worth (valuation)?
Valuation information for Gedea Biotech is not publicly available.
Can I buy Gedea Biotech stock?
Gedea Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gedea Biotech's last funding round?
Gedea Biotech's most recent funding round was Grant on February 29, 2024.
Who are the main investors in Gedea Biotech?
Key investors in Gedea Biotech include European Innovation Council Fund, Vinnova, Swelife, LU Ventures.
Will Gedea Biotech IPO soon?
No public IPO plans have been announced for Gedea Biotech.
How can I track Gedea Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Gedea Biotech's shares on secondary markets.